In the News

Share

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

460 News Items found
Laboratory coats hanging from pegs
MSK Research Highlights, November 23, 2022

New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute finds tumor-associated macrophages that express a specific transcription factor might be targeted to improve immunotherapy; examines how different mutational processes impact individual cell genomes in cancer; sheds new light on cell senescence in cancer; and offers new models to aid the search for new treatments for mesothelioma.
Finding
photo of sample blood vials
Could a Blood Test Detect Early-Stage Cancers?

A sensitive assay for detecting tumor DNA in the blood performed well in patients and may herald the development of a blood test for cancer screening.
In the Lab
Computational biologist Quaid Morris
Machine Learning Helps Clarify the Risk Connected to Age-Related Blood Condition

A new study shows how evolution and natural selection influence clonal hematopoiesis, an aging-related blood condition that increases the risk of blood cancer and cardiovascular disease.
Simon Powell
An Interview With Simon Powell

Dr. Powell joined Memorial Sloan Kettering in 2008 as Chair of the Department of Radiation Oncology with a joint appointment in Sloan Kettering Institute's Molecular Biology Program.
Detail of an MSK scientist working in a lab
MSK Research Highlights, October 31, 2023

New MSK research identifies a promising immunotherapy target for acute myeloid leukemia; decodes genetic differences in tumors from patients with African ancestry; and finds a virtual mind-body fitness program reduced hospitalizations for those in active cancer treatment. A clinical trial led by MSK also resulted in the approval of a new combination therapy for non-small cell lung cancer.
Announcement
Image of As, Ts, Cs, and Gs representing genetic code
AACR Project GENIE Seeks to Advance Cancer Treatment

Eight leading cancer centers are coming together to share genomic sequencing data, in the hope of making faster progress in curing cancer.
In the Clinic
Medical oncologist Alexander Drilon
A Perfect Match: Molecular Tests Developed at MSK Guide Personalized Treatment for Lung Cancer

For personalized treatment to work, it’s important to analyze each person’s tumor for genetic mutations and find the best drugs to target those mutations.
ContactTracing graphic
New Research Shows How Cancer Rewires a Key Immune Pathway To Spread

A collaboration between MSK and Weill Cornell Medicine discovered a new relationship between cancer cells and the immune system, and shows how cancer can selfishly hijack a normally helpful immune pathway.
Patient Story
MSK gynecologic surgeon Dr. Mario Leitao and Dr. Anh Le.
Full Circle: MSK Patient Survives Deadly Cervical Cancer and Returns to Train as Doctor

Read about a medical student treated at MSK for aggressive cervical cancer who later returned to train alongside MSK surgeons.
Event
MSK commencement
2018 MSK Convocation and Commencement Celebrates Distinguished Scientists and Scholars

Degrees were presented and awards were given at the 39th annual ceremony, held on May 30.